3/26
07:09 am
nspr
InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024 [Yahoo! Finance]
High
Report
InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024 [Yahoo! Finance]
3/26
07:00 am
nspr
InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024
High
Report
InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024
3/23
02:04 am
nspr
InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/15
02:15 am
nspr
InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/7
10:43 am
nspr
InspireMD, Inc. (NASDAQ:NSPR) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
InspireMD, Inc. (NASDAQ:NSPR) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/7
10:37 am
nspr
InspireMD, Inc. (NASDAQ:NSPR) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
InspireMD, Inc. (NASDAQ:NSPR) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/6
07:12 am
nspr
InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
3/6
07:00 am
nspr
InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
Medium
Report
InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
2/28
07:00 am
nspr
InspireMD to Report Fourth Quarter and Full-Year 2023 Financial Results and Provide Corporate Business Update on Wednesday, March 6th
Medium
Report
InspireMD to Report Fourth Quarter and Full-Year 2023 Financial Results and Provide Corporate Business Update on Wednesday, March 6th
2/28
02:01 am
nspr
InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/20
02:11 am
nspr
InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/12
07:13 am
nspr
InspireMD Appoints Principal Investigators for C-GUARDIANS II Clinical Trial of the SwitchGuard™ Neuroprotection System [Yahoo! Finance]
Low
Report
InspireMD Appoints Principal Investigators for C-GUARDIANS II Clinical Trial of the SwitchGuard™ Neuroprotection System [Yahoo! Finance]
2/12
07:00 am
nspr
InspireMD Appoints Principal Investigators for C-GUARDIANS II Clinical Trial of the SwitchGuard™ Neuroprotection System
Low
Report
InspireMD Appoints Principal Investigators for C-GUARDIANS II Clinical Trial of the SwitchGuard™ Neuroprotection System
2/12
01:03 am
nspr
InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/5
01:13 pm
nspr
InspireMD's (NSPR) CE Mark Recertification to Boost CGuard EPS [Yahoo! Finance]
Medium
Report
InspireMD's (NSPR) CE Mark Recertification to Boost CGuard EPS [Yahoo! Finance]
2/4
01:07 am
nspr
InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
1/31
07:12 am
nspr
InspireMD Receives CE Mark Recertification Under EU's New Medical Device Regulation (MDR) Regulatory Framework [Yahoo! Finance]
Low
Report
InspireMD Receives CE Mark Recertification Under EU's New Medical Device Regulation (MDR) Regulatory Framework [Yahoo! Finance]
1/31
07:00 am
nspr
InspireMD Receives CE Mark Recertification Under EU’s New Medical Device Regulation (MDR) Regulatory Framework
Low
Report
InspireMD Receives CE Mark Recertification Under EU’s New Medical Device Regulation (MDR) Regulatory Framework
1/27
04:40 am
nspr
InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
1/23
09:01 am
nspr
We're Hopeful That InspireMD (NASDAQ:NSPR) Will Use Its Cash Wisely [Yahoo! Finance]
Low
Report
We're Hopeful That InspireMD (NASDAQ:NSPR) Will Use Its Cash Wisely [Yahoo! Finance]
1/17
01:38 pm
nspr
Global Carotid and Renal Artery Stents Pipeline Research Report 2023: Stages of Development, Key Segments, Region and Countries, Regulatory Path and Competitive Landscape [Yahoo! Finance]
Medium
Report
Global Carotid and Renal Artery Stents Pipeline Research Report 2023: Stages of Development, Key Segments, Region and Countries, Regulatory Path and Competitive Landscape [Yahoo! Finance]
1/3
07:04 am
nspr
InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice President and General Manager of North America [Yahoo! Finance]
Medium
Report
InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice President and General Manager of North America [Yahoo! Finance]
1/3
07:00 am
nspr
InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice President and General Manager of North America
Medium
Report
InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice President and General Manager of North America